Stanley Chen
Foot & Ankle Surgery · Briarwood, NYNPI 1831350545
Payments from drug & device makers
Across 103 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$765
- Sandoz$365
- Advanced Oxygen Therapy Inc.$160
- Alfasigma USA, Inc.$130
- Kerecis Limited$113
- Amgen$106
- plus $560 from 15 others
What the payments were for
- Food & beverage$2,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 36 | $765 |
| Sandoz | 17 | $365 |
| Advanced Oxygen Therapy Inc. | 4 | $160 |
| Alfasigma USA, Inc. | 8 | $130 |
| Kerecis Limited | 2 | $113 |
| Amgen | 6 | $106 |
| Stryker | 5 | $105 |
| AbbVie | 4 | $74 |
| Merck | 5 | $72 |
| Axogen | 1 | $59 |
| Bioventus LLC | 3 | $51 |
| Sebela Pharmaceuticals Inc. | 2 | $32 |
| Orthofix Medical, Inc. | 1 | $29 |
| Organogenesis Inc. | 2 | $28 |
| Zimmer Biomet | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $22 |
| Convatec Inc. | 1 | $16 |
| Medline Industries LP | 1 | $15 |
| Medartis Inc. | 1 | $15 |
| Treace Medical Concepts, Inc. | 1 | $13 |
| Biocomposites Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,199 in reported general payments places this provider in the 50th percentile of 652 foot & ankle surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 21 | $6,074 |
| Mupirocin | 29 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $765 | $6,07421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in Briarwood
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4.1M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$365K
- Edward AzarBrooklyn$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.